Leiomyoma with bizarre nuclei: A current update

E Guo, C Li, Y Hu, K Zhao, Q Zheng… - International Journal of …, 2022 - Taylor & Francis
Leiomyoma with bizarre nuclei (LBN), also known as symplastic leiomyoma, is a histological
subtype of benign leiomyoma with bizarre cells and nuclear atypia. Differentiating LBN from …

miR‐149‐3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma

X Lu, L Jing, S Liu, H Wang… - International Journal of …, 2022 - Wiley Online Library
Background. Endocrine disruption is an important factor in the development of endometrial
cancer. Expression of miR‐149‐3p is observed in some cancer types, while its role in …

The rare, unexpected condition of a twisted leiomyoma in Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: etiopathogenesis, diagnosis and management. Our …

F Romano, S Carlucci, G Stabile, G Mirenda… - International Journal of …, 2021 - mdpi.com
Uterine leiomyomas are a common finding in medical practice, but their frequency changes
drastically when contextualized in a syndrome, as in the following case. A 50-year-old …

A label-free proteomic approach for the identification of biomarkers in the exosome of endometrial cancer serum

E Sommella, V Capaci, M Aloisio, E Salviati… - Cancers, 2022 - mdpi.com
Simple Summary Endometrial cancers (ECs) are mostly adenocarcinomas arising from the
inner part of the uterus. The identification of serum biomarkers may be useful for an early …

Phospho-DIGE Identified Phosphoproteins Involved in Pathways Related to Tumour Growth in Endometrial Cancer

V Capaci, G Arrigoni, L Monasta, M Aloisio… - International Journal of …, 2023 - mdpi.com
Endometrial cancer (EC) is the most common gynecologic malignancy of the endometrium.
This study focuses on EC and normal endometrium phosphoproteome to identify …

A Multi-omics approach revealed common dysregulated pathways in type one and type two endometrial cancers

V Capaci, L Monasta, M Aloisio, E Sommella… - International Journal of …, 2023 - mdpi.com
Endometrial cancer (EC) is the most frequent gynecologic cancer in postmenopausal
women. Pathogenetic mechanisms that are related to the onset and progression of the …

Gel-based proteomic identification of suprabasin as a potential new candidate biomarker in endometrial cancer

F Celsi, L Monasta, G Arrigoni, I Battisti… - International Journal of …, 2022 - mdpi.com
Endometrial cancer (EC) is the most frequent gynaecologic cancer in postmenopausal
women. We used 2D-DIGE and mass spectrometry to identify candidate biomarkers in …

Characteristics of submucous myomas and the risk of anemia

G Ricci, F Scrimin, A Sartore, M Borelli, G Zito… - Medicina, 2022 - mdpi.com
Background and Objectives: Uterine fibroids still represent the most common indication for
hysterectomy for benign pathologies. In the United States, more than 479,000 …

N-glycan structures of target cancer biomarker characterized by two-dimensional gel electrophoresis and mass spectrometry

S Liu, X Jiang, Z Shang, Y Ji, H Wang, Z Wang… - Analytica Chimica …, 2020 - Elsevier
Glycoproteins are important biomarkers for cancers, while most glycoproteomics biomarkers
suffering from low sensitivity and specificity due to their uncharacterized glycan structures …

[HTML][HTML] Proteins involved in oxidative stress in leiomyoma tissues treated with ulipristal acetate

B Ura, L Monasta… - Molecular …, 2021 - spandidos-publications.com
Uterine leiomyoma presents the highest incidence among benign tumors of the female
reproductive tract. The present study compared the proteome of leiomyoma treated with …